CIK 0001570562 · Accelerated filer
Evolus, Inc.
Sign in to watch- Ticker
- EOLS
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 461385614
- Phone
- (949) 284-4555
- Business address
- 520 NEWPORT CENTER DRIVE, SUITE 1200, NEWPORT BEACH, CA, 92660
- Former names
- Evolus, Inc.
- 4 Open-market sale See Remarks sold 27,603 shares at $13.92 ($384,350)
- 4 Open-market sale Chief Financial Officer sold 5,672 shares at $13.92 ($78,978)
- 4 Open-market sale See Remarks sold 96,566 shares at $13.92 ($1,344,604)
- 8-K Event Material agreement
- 424B5 Offering Prospectus
- S-8 Other Securities Offered to Employees in Benefit Plans
- 10-K Report Annual Report
- 8-K Event Results of operations
- 4 Planned sale See Remarks sold 7,706 shares at $13.08 ($100,804)
- 4 Planned sale See Remarks sold 1,821 shares at $13.08 ($23,821)
- 4 Planned sale Chief Financial Officer sold 1,821 shares at $13.08 ($23,821)
- SC 13G Stake Amended Statement of Ownership
- SC 13G/A Stake Amended Statement of Ownership
- SC 13G/A Stake Amended Statement of Ownership
- SC 13G Stake Amended Statement of Ownership
- SC 13G/A Stake Amended Statement of Ownership
- SC 13G/A Stake Amended Statement of Ownership
- 4 Grant or award Director acquired 6,464 shares (grant or award)
- 4 Grant or award Director acquired 6,464 shares (grant or award)
- 4 Grant or award Director acquired 6,464 shares (grant or award)
Page 8 of 28 · 558 filings